1995 Results

People

  1. Kris
    Kris
  2. Motzer
    Motzer
  3. Scher
    Scher
  4. Saltz
    Saltz
  5. Schwartz
    Schwartz
  6. Hudis
    Hudis
  7. Kelsen
    Kelsen
  8. Rosen
    Rosen
  9. Marks
    Marks
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)
  7. Sloan Kettering Institute Faculty (227)
  8. Hematologic Malignancies, Division of (224)
  9. Genitourinary Oncology Service (203)
  10. Molecular Pharmacology and Chemistry Program Faculty (172)
  1. "antineoplastic agents"
Formats
  1. Journal Article (1901)
  2. Review (47)
  3. Conference Paper (23)
  4. Editorial (7)
  5. Research Letter (6)
  6. Guidelines (4)
  7. Book Section (3)
  8. Correspondence (2)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)

More Groups

People
  1. Mark Kris (77)
  2. Robert Motzer (70)
  3. Howard Scher (58)
  4. Gary Schwartz (52)
  5. Leonard Saltz (52)
  6. Ting-Chao Chou (50)

More People

Years
  1. 2025 (16)
  2. 2024 (65)
  3. 2023 (49)
  4. 2022 (49)
  5. 2021 (11)
  6. 2020 (4)

More Years

Publications
  1. Clinical Cancer Research (114)
  2. Journal of Clinical Oncology (111)
  3. Cancer (70)
  4. Seminars in Oncology (51)
  5. New England Journal of Medicine (43)
  6. Cancer Research (40)

More Publications

Publishers
  1. Elsevier Inc. (240)
  2. American Association for Cancer Research (187)
  3. Springer (175)
  4. American Society of Clinical Oncology (129)
  5. Wiley Blackwell (112)
  6. Nature Publishing Group (92)

More Publishers

Results (1995)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sézary syndrome receiving placebo
    Journal Article

    Prince, H. M.; Duvic, M.; Martin, A.; Sterry, W.; Assaf, C.; Straus, D. J.
    Journal of the American Academy of Dermatology (2012)

    Fulltext@MSK | Save
  • Antibody-drug conjugate technology development for hematologic disorders
    Journal Article

    Bander, N. H.; Czuczman, M. S.; Younes, A.
    Clinical Advances in Hematology & Oncology (2012)

    Fulltext@MSK | Save
  • The 2011 Gordon Wilson Lecture: Overcoming resistance to targeted cancer drugs
    Journal Article

    Sawyers, C. L.
    Transactions of the American Clinical and Climatological Association (2012)

    Fulltext@MSK | Save
  • Long-term effects of chemo on the cognitive function of cancer patients
    Journal Article

    Jim, H.; Rodin, G.; Ahles, T. A.
    Oncology (Norwalk) (2012)

    Fulltext@MSK | Save
  • Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0
    Journal Article

    Chen, A. P.; Setser, A.; Anadkat, M. J.; Cotliar, J.; Olsen, E. A.; Garden, B. C.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2012)

    Fulltext@MSK | Save
  • The use of acellular dermal matrices in two-stage expander/implant reconstruction: a multicenter, blinded, randomized controlled trial
    Journal Article

    McCarthy, C. M.; Lee, C. N.; Halvorson, E. G.; Riedel, E.; Pusic, A. L.; Mehrara, B. J.; Disa, J. J.
    Plastic and Reconstructive Surgery (2012)

    Fulltext@MSK | Save
  • Outcomes of the management of post-chemotherapy retroperitoneal lymph node dissection-associated anejaculation
    Journal Article

    Hsiao, W.; Deveci, S.; Mulhall, J. P.
    BJU International (2012)

    Fulltext@MSK | Save
  • Provocative pearls in diagnosing and treating acute promyelocytic leukemia
    Journal Article

    Stein, E. M.; Tallman, M. S.
    Oncology (Norwalk) (2012)

    Fulltext@MSK | Save
  • A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine
    Journal Article

    Krop, I. E.; LoRusso, P.; Miller, K. D.; Modi, S.; Yardley, D.; Rodriguez, G.; Guardino, E.; Lu, M.; Zheng, M.; Girish, S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma
    Journal Article

    Rosenzweig, K. E.; Zauderer, M. G.; Laser, B.; Krug, L. M.; Yorke, E.; Sima, C. S.; Rimner, A.; Flores, R.; Rusch, V.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save